Integra Lifesciences Holdings Corp share price logo

Integra Lifesciences Holdings Corp Share Price

NASDAQ: IART

Small Cap

$9.21

-0.17

(-1.81%)

as on

Integra Lifesciences Holdings Corp Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $9.04
    $9.39
    downward going graph

    1.85%

    Downside

    1.95%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.70
    $22.27
    downward going graph

    5.54%

    Downside

    141.80%

    Upside

    downward going graph

Integra Lifesciences Holdings Corp share price movements today

Previous Close
$9.38
Open
$9.38
Volume
777.4K
Day's Low - High
$9.04 - $9.39
52 Week Low - High
$8.70 - $22.27

Integra Lifesciences Holdings Corp Historical Returns

1 Month Return
-19.16 %
3 Month Return
-27.1 %
1 Year Return
-57.58 %
3 Year Return
-83.42 %
5 Year Return
-86.63 %

Integra Lifesciences Holdings Corp Stock Fundamentals & Key Indicators

Check Integra Lifesciences Holdings Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$731.1M

EPS (TTM)

2.3405

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

67.94

Industry PE ratio

-4.397180327868853

PEG Ratio

0.6691

EBITDA

297.7M

Revenue (TTM)

1.6B

Profit Margin

-31.58%

Return On Equity TTM

-39.90%

Integra Lifesciences Holdings Corp Stock Valuation

Track how Integra Lifesciences Holdings Corp P/E has moved over time to understand its valuation trends.

Integra Lifesciences Holdings Corp in the last 5 years

  • Overview

  • Trends

Lowest (8.41x)

September 30, 2025

Industry (-4.40x)

March 28, 2026

Today (67.94x)

March 28, 2026

Highest (25.47x)

March 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 67.94x

Integra Lifesciences Holdings Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Integra Lifesciences Holdings Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Integra Lifesciences Holdings Corp image
Integra Lifesciences Holdings Corp
BUY$731.1M-86.63%67.94-31.58%
Boston Scientific Corp. image
Boston Scientific Corp.
BUY$104.3B80.98%36.1714.44%
Stryker Corporation image
Stryker Corporation
BUY$127.4B35.88%39.712.92%
Medtronic Plc image
Medtronic Plc
BUY$112.6B-26.5%24.4913.00%
Abbott Laboratories image
Abbott Laboratories
BUY$181.7B-14.81%28.1114.72%
See all

Stock Returns calculator for Integra Lifesciences Holdings Corp Stock including INR - Dollar returns

The Integra Lifesciences Holdings Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Integra Lifesciences Holdings Corp investment value today

Current value as on today

₹52,971

Returns

₹47,029

(-47.03%)

Returns from Integra Lifesciences Holdings Corp Stock

₹57,538 (-57.54%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Integra Lifesciences Holdings Corp Stock

Based on 20 analysts

BUY

50.00%

Buy

35.00%

Hold

15.00%

Sell

Based on 20 analysts, 50% of analysts recommend a 'BUY' rating for Integra Lifesciences Holdings Corp. Average target price of $15.57

Integra Lifesciences Holdings Corp Share Price Target

Get share price movements and forecasts by analysts on Integra Lifesciences Holdings Corp.

What analysts predicted

40.85%UPSIDE

Target Price

$15.57

Current Price

$9.21

Analyzed by

20 Analysts

Target

$15.57

Integra Lifesciences Holdings Corp target price $15.57, a slight upside of 40.85% compared to current price of $9.21. According to 20 analysts rating.

Integra Lifesciences Holdings Corp Stock’s Investor Sentiment and Interest

Search interest for Integra Lifesciences Holdings Corp Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:28% versus previous 30 day period

Integra Lifesciences Holdings Corp Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
382
397
368
418
380
442
382
415
402
434
Gross Profit
218
226
206
225
200
249
194
209
226
215
Operating Income
26
36
3
-3
-8
35
-15
-512
40
556
EBITDA
62
73
38
40
34
79
25
-472
54
65
Interest Expense
13
13
13
18
19
18
20
21
22
23
Depreciation
3
30
30
36
35
37
37
37
38
38
Income Before Tax
18
28
-5
-15
-20
22
-30
-530
-6
4
Income Tax Expense
0
9
-1
-2
-9
3
-4
-46
-1
6
Net Income
19
19
-3
-12
-10
19
-25
-484
-5
-1
Net Profit Margin
5.10%
5.00%
-0.89%
-2.97%
-2.81%
4.39%
-6.61%
-116.47%
-1.34%
-0.39%

Integra Lifesciences Holdings Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
992
1,188
1,472
1,517
1,371
1,542
1,557
1,541
1,610
1,635
Gross Profit
642
752
900
952
851
944
970
884
882
845
Operating Income
115
44
110
93
151
197
238
111
28
68
EBITDA
231
135
241
223
267
366
384
255
193
-326
Interest Expense
25
35
64
53
71
50
49
51
70
86
Depreciation
-
88
110
109
116
16
118
123
140
151
Income Before Tax
90
11
57
60
93
214
213
81
-18
-563
Income Tax Expense
15
-53
-3
9
-40
45
33
13
-11
-47
Net Income
74
64
60
50
133
169
180
67
-6
-516
Net Profit Margin
7.52%
5.45%
4.13%
3.31%
9.76%
10.96%
11.59%
4.39%
-0.43%
-31.58%

Integra Lifesciences Holdings Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
19
-3
-12
-10
19
-25
-484
-5
-1
Operating Cash Flow
58
15
40
22
50
-11
8
40
11
Investing Cash Flow
-57
-53
-322
-10
-4
-35
-21
-15
-34
Financing Cash Flow
-6
358
-93
-19
-7
35
-21
-10
24
Change in Cash
2
315
-376
0
31
-7
-21
14
2

Integra Lifesciences Holdings Corp Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
64
60
50
133
169
180
67
-6
-516
Operating Cash Flow
114
199
231
203
312
264
139
129
50
Investing Cash Flow
-1,221
-49
-162
-68
-161
-58
-94
-390
-108
Financing Cash Flow
1,168
-180
-8
121
-98
-251
-229
237
28
Change in Cash
72
-36
60
271
43
-56
-180
-30
-11

Global Institutional Holdings in Integra Lifesciences Holdings Corp

Funds
Holdings
State Street Corp
3.58%
The Goldman Sachs Group Inc
1.97%
Geode Capital Management, LLC
1.99%
Fuller & Thaler Asset Management Inc
9.33%
Morgan Stanley - Brokerage Accounts
4.91%
See all

Insights on Integra Lifesciences Holdings Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -484.07M → -1.70M (in $), with an average increase of 4537.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 402.06M → 434.92M (in $), with an average increase of 7.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 11.9% return, outperforming this stock by 69.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Integra Lifesciences Holdings Corp has experienced a drawdown of -83.4%, however Boston Scientific Corp. resisted the overall trend and outperformed by 82.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, IART stock has moved down by -19.2%

About Integra Lifesciences Holdings Corp

integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
OrganisationIntegra Lifesciences Holdings Corp
Headquarters1100 Campus Road, Princeton, NJ, United States, 08540
IndustryHealth Technology
CEOMs. Mojdeh Poul
E-voting on sharesClick here to vote

Key Management of Integra Lifesciences Holdings Corp

Name

Title

Laurene Isip

Vice President of Global Corporate Communications & Public Relations

Mr. Jeffrey A. Mosebrook

Senior VP of Finance & Principal Accounting Officer

Christopher Ward

Senior Director of Investor Relations

Mr. Michael J. McBreen

Executive VP & President of Codman Specialty Surgical

Mr. Harvinder Pal Singh

Executive VP & President of International Business

Ms. Mojdeh Poul

President, CEO & Director

Mr. Teshtar Elavia

Corporate VP & Chief Technology Officer

Mr. Michael D. Hutchinson

Executive VP, Chief Legal Officer & Secretary

Ms. Lea Daniels Knight

Executive VP & CFO

Mr. Robert T. Davis Jr.

Executive VP & President of Tissue Technologies

FAQs

What is Integra Lifesciences Holdings Corp share price today?

Integra Lifesciences Holdings Corp share price today is $9.21 as on at the close of the market. Integra Lifesciences Holdings Corp share today touched a day high of $9.39 and a low of $9.04.

What is the 52 week high and 52 week low for Integra Lifesciences Holdings Corp share?

Integra Lifesciences Holdings Corp share touched a 52 week high of $22.27 on and a 52 week low of $8.7 on . Integra Lifesciences Holdings Corp stock price today i.e. is closed at $9.21,which is 58.64% down from its 52 week high and 5.86% up from its 52 week low.

What is Integra Lifesciences Holdings Corp's market capitalisation today?

Integra Lifesciences Holdings Corp market capitalisation is $0.00T as on .

How to invest in Integra Lifesciences Holdings Corp Stock (IART) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Integra Lifesciences Holdings Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Integra Lifesciences Holdings Corp Shares that will get you 0.1629 shares as per Integra Lifesciences Holdings Corp share price of $9.21 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Integra Lifesciences Holdings Corp Stock (IART) from India?

Indian investors can start investing in Integra Lifesciences Holdings Corp (IART) shares with as little as ₹94.651 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Integra Lifesciences Holdings Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Integra Lifesciences Holdings Corp share’s latest price of $9.21 as on March 28, 2026 at 1:29 am IST, you will get 1.0858 shares of Integra Lifesciences Holdings Corp. Learn more about fractional shares .

What are the returns that Integra Lifesciences Holdings Corp has given to Indian investors in the last 5 years?

Integra Lifesciences Holdings Corp stock has given -86.63% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?